MedTrace Logo

Improving COVID-19 Vaccine Uptake Among Black and Latino Youth

NCT05293392 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 5792

Last updated 2023-09-28

Study results available
· View outcomes & findings →

Summary

Black and Latino youth may be less likely to get the COVID-19 vaccine than White youth. In this study we will work with community members to come up with ways to help Black and Latino families learn more about the COVID-19 vaccine and get the COVID-19 vaccine. We will test these ideas out in pediatric primary care clinics. This study will help us make sure that all youth have an equal chance of getting the COVID-19 vaccine.

Conditions

Interventions

BEHAVIORAL

Culturally-Tailored COVID-19 Vaccine Uptake Intervention

This is a multi-component intervention to increase COVID-19 vaccine uptake among youth that was co-created with community partners and refined with qualitative feedback from Black and Latino youth and parents. The intervention consists of culturally-tailored educational materials to increase awareness about the COVID-19 vaccine, culturally-sensitive communication strategies employed by pediatric primary care providers and community health workers, and strategies to facilitate and standardize access to the COVID-19 vaccine in the primary care clinic.

BEHAVIORAL

Standard Care

Standard care includes routine offer of the COVID-19 vaccine and counseling about the COVID-19 vaccine by pediatric primary care providers.

Sponsors & Collaborators

  • National Institute of General Medical Sciences (NIGMS)

    collaborator NIH

  • University of Delaware

    collaborator OTHER

  • ChristianaCare

    collaborator OTHER

  • Nemours Children's Health System

    lead OTHER

Principal Investigators

  • Thao-Ly T Phan-Vo, MD, MPH · Nemours Children's Health

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-31
Primary Completion
2022-05-20
Completion
2022-05-20

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05293392 on ClinicalTrials.gov